Ono M
Department of Molecular Biology, School of Medicine, Kitasato University, Kanagawa, Japan.
Dev Biol Stand. 1989;70:69-81.
Conventional safety tests are sufficient for inspecting biological products provided no retrovirus-like particle is present in substrate cells. But if so, changing the cell line to another would be the best course of action but of course unwise for cell lines derived from rodents due to the difficulty in obtaining a particle-free cell line. Otherwise, biological and/or physical means for eliminating such particles would be best. A general procedure should be available for inactivating retroviruses in vaccines. A standard method for selectively inactivating the biological activity of nucleic acid but not protein by physical (e.g., UV or radiation), chemical, or biological (e.g., nuclease treatment following particle disruption) treatment should be developed since it is known that the essential biological activity of the particles is on the RNA genome. If a product is too unstable to permit application of these methods, elimination of the particles can be carried out by physical means since they are sufficiently large.
如果底物细胞中不存在逆转录病毒样颗粒,常规安全性测试足以检测生物制品。但如果存在这种颗粒,更换细胞系是最佳做法,不过对于源自啮齿动物的细胞系而言,这并不明智,因为难以获得无颗粒的细胞系。否则,采用生物和/或物理方法消除此类颗粒最为理想。应当有一个通用程序用于灭活疫苗中的逆转录病毒。鉴于已知颗粒的基本生物活性存在于RNA基因组上,应开发一种标准方法,通过物理(如紫外线或辐射)、化学或生物(如颗粒破坏后进行核酸酶处理)处理来选择性地灭活核酸而非蛋白质的生物活性。如果产品过于不稳定而无法应用这些方法,由于颗粒足够大,可以通过物理手段消除它们。